Patents Assigned to SHANGHAI JW INFLINHIX CO., LTD.
  • Protein for neutralizing programmed necrocytosis promotion antibody, and application of protein
    Patent number: 11434270
    Abstract: Provided is polypeptide which derives from wild type TNF a and inhibits necrocytosis. The polypeptide contains 10-200 amino acid residues and a sequence QLVVPSE. Also provided is a pharmaceutical composition containing polypeptide. The polypeptide and the pharmaceutical composition containing the polypeptide are capable of inhibiting necrocytosis, thereby being used for treating inflammatory diseases.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: September 6, 2022
    Assignee: SHANGHAI JW INFLINHIX CO., LTD.
    Inventors: Shisong Jiang, Wenshu Lu
  • Antibody facilitating programmed necrosis of cells and application thereof
    Patent number: 11319366
    Abstract: The present invention provides an antibody facilitating programmed necrosis of cells. The antibody can cause programmed necrosis of cells in the presence of tumor necrosis factor (TNF). Therefore, an inhibitor for the antibody can be used in the treatment of inflammatory diseases. Further, the present invention provides the application of the antibody facilitating programmed necrosis of cells in the inflammatory disease prognosis.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: May 3, 2022
    Assignee: SHANGHAI JW INFLINHIX CO., LTD.
    Inventors: Shisong Jiang, Wenshu Lu